Maurice Gordon

Experts from Cambridge Associates, Coller Capital, and Guardian Life discuss why distributions to LPs are at record-high levels.

Experts from Cambridge Associates, Coller Capital, and Guardian Life discuss the impact of LP dry powder earmarked for co-investments that’s not included in most PE fundraising data.

Experts from Cambridge Associates, Coller Capital, and Guardian Life discuss why there is more variation in fee structures than ever before.

Experts from Cambridge Associates, Coller Capital, and Guardian Life explain why co-investments are increasingly popular, how they are performing, and how to be aware of adverse selection.

Experts from Cambridge Associates, Coller Capital, and Guardian Life discuss GPs needing capital for “outside the strike zone” deals, and how LPs need to carefully track whether a co-investment opportunity is within the strike zone of a GP.

Experts from Cambridge Associates, Guardian Life, and Coller Capital discuss why institutional investors are allocating to infrastructure, and how a new index is helping define a performance benchmark for investors in the sector.

Guardian Life’s Maurice Gordon discusses what he looks for in a GP and how technology will improve transparency.

Guardian is seeking a partner to help with deal flow in co-investments.

Three performance experts from Cambridge Associates, Guardian Life and Coller Capital discuss new evidence of adverse selection in LP co-investing, among other topics.